These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 2449)

  • 61. [Hemodynamic correlates of selective beta 1 adrenergic receptor blockade by cordanum during hemiton monotherapy in children with primary arterial hypertension].
    Kapliev VA
    Pediatriia; 1988; (9):112. PubMed ID: 2904673
    [No Abstract]   [Full Text] [Related]  

  • 62. [Effect of beta-blockers on the cardiac rhythm variability in patients with hypertension].
    Bil'chenko AV
    Lik Sprava; 2002; (1):38-41. PubMed ID: 11944376
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Beta blockers: cardiac jacks of all trades. Uses for beta blockers range from lowering blood pressure to improving heart failure.
    Harv Heart Lett; 2011 Dec; 22(4):4-5. PubMed ID: 22319827
    [No Abstract]   [Full Text] [Related]  

  • 64. [The use of beta-blockers in patients with hypertension and chronic obstructive lung diseases].
    Libov IA; Mravian SR; Nemirovskaia AI
    Kardiologiia; 2004; 44(3):102-5. PubMed ID: 15489839
    [No Abstract]   [Full Text] [Related]  

  • 65. [Hypertension treatment with a new retard form of a beta-blocker (result of a practice study)].
    Degenring FH; Walch HG; Ziegler E
    ZFA (Stuttgart); 1981 Oct; 57(30):2093-5. PubMed ID: 6118981
    [No Abstract]   [Full Text] [Related]  

  • 66. Preserved renal perfusion during treatment of essential hypertension with the beta blocker nadolol.
    O'Connor DT; Barg AP; Duchin KL
    J Clin Pharmacol; 1982 Apr; 22(4):187-95. PubMed ID: 6124557
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Effect of nadolol in treatment of hypertension.
    Volicer L; Liang CS; Gavras H; Tifft CP; Kershaw GR; Gavras I; Griffith DL; Vukovitch R; Brunner HR
    J Clin Pharmacol; 1979; 19(2-3):137-47. PubMed ID: 33998
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Beta-blockers: no longer an option for uncomplicated hypertension.
    Bangalore S; Kamalakkannan G; Messerli FH
    Curr Cardiol Rep; 2007 Nov; 9(6):441-6. PubMed ID: 17999868
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Beta-Blockers in the Treatment of Hypertension in the 90's: Experience with Tertatolol. Conference proceedings. Istanbul, Turkey, October 19, 1993.
    Cardiology; 1993; 83 Suppl 1():1-72. PubMed ID: 7903209
    [No Abstract]   [Full Text] [Related]  

  • 70. European experience with artex: the Tertatolol International Multicentre Study (TIMS).
    Laher MS
    Cardiology; 1993; 83 Suppl 1():25-31. PubMed ID: 7903212
    [TBL] [Abstract][Full Text] [Related]  

  • 71. [Drug information. Metoprolol (Seloken, Hässle)].
    Kampmann JP
    Ugeskr Laeger; 1975 Dec; 137(51):3046-7. PubMed ID: 837
    [No Abstract]   [Full Text] [Related]  

  • 72. Preliminary report on the haemodynamic response of hypertensive patients treated with a beta blocker (ICI 66082).
    Amery A; Billiet L; Joossens JV; Meekers J; Reybrouck T; Van Mieghem W
    Acta Clin Belg; 1973; 28(5):358-63. PubMed ID: 4149691
    [No Abstract]   [Full Text] [Related]  

  • 73. A case of drug-induced pneumonitis caused by carvedilol.
    Markou N; Antzoulatos N; Haniotou A; Kanakaki M; Parissis J; Damianos A
    Respiration; 2004; 71(6):650-2. PubMed ID: 15627880
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Beta blockers. What you need to know about these blood pressure drugs.
    Harv Health Lett; 2012 Jun; 37(8):7. PubMed ID: 22774256
    [No Abstract]   [Full Text] [Related]  

  • 75. Beta blockers in hypertension.
    Cruickshank JM
    Lancet; 2010 Aug; 376(9739):415; author reply 415-6. PubMed ID: 20692524
    [No Abstract]   [Full Text] [Related]  

  • 76. Overview of clinical safety and efficacy of tertatolol.
    Vivet P
    Cardiology; 1993; 83 Suppl 1():41-50. PubMed ID: 7903214
    [TBL] [Abstract][Full Text] [Related]  

  • 77. First line treatment for uncomplicated hypertension: time for a rethink.
    Leone AM; De Caterina AR
    Maturitas; 2011 Jan; 68(1):1-2. PubMed ID: 20934820
    [No Abstract]   [Full Text] [Related]  

  • 78. Initial clinical experience with I.C.I. 66.082, a new beta-adrenergic blocking agent, in hypertension.
    Hansson L; Aberg H; Jameson S; Karlberg B; Malmcrona R
    Acta Med Scand; 1973 Dec; 194(6):549-50. PubMed ID: 4149321
    [No Abstract]   [Full Text] [Related]  

  • 79. [Evaluation of antihypertensive agents for the treatment of mild and intermediate hypertension--results of 4 years of prospective studies].
    Kuramoto K; Matsushita S; Kuwajima I; Mifune J; Sakai M; Iwasaki T; Murakami M
    Nihon Rinsho; 1979 Oct; 37(10):3465-71. PubMed ID: 522256
    [No Abstract]   [Full Text] [Related]  

  • 80. Crossover trial comparison of enalapril maleate and trichlormethiazide in the treatment of essential hypertension: emphasis on the quality of life.
    Kobayashi A; Hayashi H; Kisamori K; Ishizaka K; Yamazaki N
    Intern Med; 1992 Feb; 31(2):165-73. PubMed ID: 1600261
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.